Marcaine/ Epinephrine 0.5% Inj
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. It is essential to follow the instructions carefully. This medication is administered via injection.
Storing and Disposing of Your Medication
This medication will be administered in a hospital or doctor's office, so you will not need to store it at home.
Missing a Dose
Since this medication is given as needed in a healthcare setting, you will not need to worry about missing a dose. The healthcare provider will administer the medication according to your specific needs.
Lifestyle & Tips
- Avoid touching or manipulating the numb area until sensation returns to prevent injury.
- Follow post-procedure instructions carefully, especially regarding activity restrictions.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of acidosis (too much acid in the blood):
+ Confusion
+ Fast breathing
+ Fast heartbeat
+ Irregular heartbeat
+ Severe stomach pain, upset stomach, or vomiting
+ Excessive sleepiness
+ Shortness of breath
+ Feeling extremely tired or weak
Signs of methemoglobinemia (a rare but potentially life-threatening condition):
+ Blue or gray discoloration of the lips, nails, or skin
+ Irregular heartbeat
+ Seizures
+ Severe dizziness or fainting
+ Severe headache
+ Excessive sleepiness
+ Feeling extremely tired or weak
+ Shortness of breath
Other severe side effects:
+ Feeling extremely hot or cold
+ Dizziness or fainting
+ Lightheadedness, sleepiness, confusion, or blurred vision
+ Balance problems
+ Restlessness
+ Anxiety
+ Changes in speech
+ Numbness or tingling in the mouth
+ Metallic taste
+ Ringing in the ears
+ Shakiness
+ Twitching
+ Seizures
+ Breathing difficulties, slow breathing, or shallow breathing
+ Abnormal burning, numbness, or tingling sensations
+ Feeling nervous and excitable
+ Headache
+ Severe stomach upset or vomiting
+ Abnormal heartbeat, chest pain, or pressure
+ Fever or chills
+ Sneezing
+ Excessive sweating
+ Skin reactions at the injection site, such as burning, color changes, pain, skin breakdown, or swelling
* Spinal-related side effects:
+ Urination difficulties
+ Loss of bladder or bowel control
+ Erectile dysfunction
+ Long-lasting burning, numbness, tingling, or paralysis in the lower half of the body
+ Back pain
+ Stiff neck
+ Sensitivity to bright lights
Other Possible Side Effects
Like all medications, this drug can cause side effects, although not everyone will experience them. If you have any side effects that bother you or do not go away, contact your doctor for advice. This is not an exhaustive list of possible side effects. If you have questions or concerns, discuss them with your doctor.
Reporting Side Effects
You can report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Feeling lightheaded, dizzy, or faint
- Ringing in your ears (tinnitus)
- Numbness or tingling around your mouth
- A metallic taste in your mouth
- Blurred vision or difficulty seeing clearly
- Tremors or muscle twitching
- Feeling anxious or restless
- Slurred speech
- Feeling unusually sleepy or confused
- Seizures
- Difficulty breathing or shortness of breath
- Chest pain or discomfort
- Feeling your heart race or beat irregularly (palpitations)
- Unusual weakness or numbness spreading beyond the intended area
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have to this medication, its components, or other substances, including foods and drugs. Describe the allergic reaction you experienced, such as symptoms and signs.
Certain health conditions, including:
+ Bleeding disorders
+ Abnormal heart rhythms
+ Blood infections or infections at the site where the medication will be administered
+ Low blood pressure (hypotension)
If you are taking specific medications, such as:
+ Antidepressants like isocarboxazid, phenelzine, or tranylcypromine
+ Medications for Parkinson's disease, including selegiline or rasagiline
+ Tricyclic antidepressants like amitriptyline, amoxapine, clomipramine, desipramine, doxepin, imipramine, nortriptyline, protriptyline, or trimipramine
+ Beta blockers like nadolol, propranolol, sotalol, or timolol
All your current medications, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This is not an exhaustive list, and it is crucial to disclose all your medications and health conditions to your doctor.
To ensure your safety, consult your doctor and pharmacist about all your medications and health problems before taking this medication. Do not initiate, stop, or modify the dose of any medication without first consulting your doctor.
Precautions & Cautions
General Precautions
It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Until the effects of this drug have worn off and you feel fully alert, avoid driving and other activities that require your full attention.
If you have a sulfite allergy, consult your doctor, as some products contain sulfites. A rare but serious blood condition called methemoglobinemia has been associated with this type of medication. Your risk may be increased if you have glucose-6-phosphate dehydrogenase (G6PD) deficiency, heart or lung problems, or are taking certain other medications. Infants under 6 months of age are also at higher risk. If you have a history of methemoglobinemia, inform your doctor.
Special Considerations
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. Not all products are suitable for children, so consult your doctor before use.
If you are pregnant, planning to become pregnant, or breastfeeding, discuss the potential benefits and risks with your doctor to ensure the best outcome for you and your baby.
Specific Warnings
Mouth: Avoid eating while your mouth is numb, as you may accidentally bite your tongue.
Spinal: This medication may cause temporary loss of sensation and motor function in the lower half of your body. Do not attempt to get out of bed or perform other activities until normal feeling and movement have returned.
Overdose Information
Overdose Symptoms:
- Severe dizziness or lightheadedness
- Profound drowsiness or loss of consciousness
- Generalized seizures
- Severe low blood pressure (hypotension)
- Slow heart rate (bradycardia) or very fast heart rate (tachycardia)
- Irregular heartbeats (arrhythmias), including life-threatening ventricular fibrillation or cardiac arrest
- Respiratory depression or apnea (stopping breathing)
What to Do:
Immediate medical attention is required. Call 911 or your local emergency number. Management involves supportive care, maintaining airway and breathing, managing seizures (e.g., with benzodiazepines), and treating cardiovascular collapse (e.g., with vasopressors, lipid emulsion therapy for bupivacaine toxicity). Call 1-800-222-1222 (Poison Control) for additional guidance.
Drug Interactions
Contraindicated Interactions
- Intravenous regional anesthesia (Bier block)
- Obstetric paracervical block (due to fetal bradycardia/death)
- Use in areas with end-arteries (e.g., fingers, toes, nose, penis, earlobe) due to risk of ischemia/necrosis.
Major Interactions
- Monoamine Oxidase Inhibitors (MAOIs): Potentiate pressor effects of epinephrine, leading to hypertensive crisis.
- Tricyclic Antidepressants (TCAs): Potentiate pressor effects of epinephrine, leading to severe prolonged hypertension.
- Ergot-type Oxytocic Drugs (e.g., methylergonovine): May cause severe persistent hypertension or cerebrovascular accidents when used with vasoconstrictors like epinephrine.
- General Anesthetics (e.g., halothane, enflurane): May sensitize the myocardium to the effects of epinephrine, increasing risk of arrhythmias.
- Other Local Anesthetics: Additive systemic toxicity.
- Antiarrhythmics (e.g., Class I antiarrhythmics like lidocaine, mexiletine): Additive cardiac effects, increased risk of toxicity.
Moderate Interactions
- Non-selective Beta-blockers (e.g., propranolol): May enhance the pressor response to epinephrine, leading to hypertension and bradycardia.
- Phenothiazines and Butyrophenones: May reverse the pressor effect of epinephrine, leading to hypotension.
- Alpha-adrenergic Blockers: May antagonize the vasoconstrictor effects of epinephrine.
- Digitalis Glycosides: Increased risk of cardiac arrhythmias with epinephrine.
Minor Interactions
- Not typically categorized for this drug combination, as most interactions are significant.
Monitoring
Baseline Monitoring
Rationale: To identify contraindications, potential drug interactions, and risk factors for toxicity.
Timing: Prior to administration
Rationale: To establish baseline and detect early signs of systemic toxicity or adverse reactions.
Timing: Prior to administration
Rationale: To ensure needle is not in a blood vessel, minimizing risk of intravascular injection and systemic toxicity.
Timing: Before and during injection
Routine Monitoring
Frequency: Every 5-15 minutes during and immediately after injection, then as clinically indicated.
Target: Within patient's normal physiological range.
Action Threshold: Significant deviations (e.g., hypotension, bradycardia, tachycardia, hypertension, desaturation) warrant immediate intervention.
Frequency: Continuously during and for at least 30 minutes after injection.
Target: Alert and oriented, no signs of CNS toxicity.
Action Threshold: Lightheadedness, dizziness, tinnitus, perioral numbness, metallic taste, visual disturbances, tremors, muscle twitching, seizures.
Frequency: Continuous during and immediately after injection, especially with large volumes or high-risk patients.
Target: Normal sinus rhythm, no significant arrhythmias.
Action Threshold: Bradycardia, tachycardia, ventricular arrhythmias, QRS widening, ST segment changes.
Frequency: As needed to assess efficacy and progression of block.
Target: Desired level of anesthesia/analgesia.
Action Threshold: Inadequate block or signs of excessive spread.
Symptom Monitoring
- Lightheadedness
- Dizziness
- Tinnitus (ringing in ears)
- Perioral numbness
- Metallic taste
- Visual disturbances (blurred vision, difficulty focusing)
- Tremors
- Muscle twitching
- Slurred speech
- Anxiety
- Restlessness
- Drowsiness
- Disorientation
- Seizures
- Loss of consciousness
- Hypotension
- Bradycardia
- Tachycardia
- Hypertension
- Arrhythmias (ventricular fibrillation, asystole)
- Respiratory depression
- Apnea
- Chest pain
- Palpitations
- Nausea
- Vomiting
Special Patient Groups
Pregnancy
Category C. Use only if the potential benefit justifies the potential risk to the fetus. Bupivacaine crosses the placenta. Epinephrine can reduce uterine blood flow. Obstetric paracervical block is contraindicated due to risk of fetal bradycardia and death.
Trimester-Specific Risks:
Lactation
L3 (Moderately safe). Bupivacaine is excreted into breast milk in small amounts. The amount ingested by the infant is generally considered too low to cause adverse effects. Epinephrine has a very short half-life and is unlikely to be present in breast milk in significant amounts. Monitor infant for drowsiness or feeding difficulties.
Pediatric Use
Use with extreme caution. Dosing must be carefully calculated based on weight and age, using the lowest effective concentration and volume. Children may be more susceptible to systemic toxicity. Avoid in very young infants if possible. The 0.75% concentration is not recommended for children.
Geriatric Use
Use with caution. Elderly patients may be more susceptible to systemic toxicity due to decreased hepatic function, reduced plasma protein binding, and altered body composition. Consider lower doses and slower injection rates. Monitor closely for CNS and cardiovascular effects.
Clinical Information
Clinical Pearls
- Always aspirate frequently and in multiple planes before and during injection to minimize the risk of accidental intravascular administration, which can lead to severe systemic toxicity.
- Use the lowest effective concentration and volume to achieve the desired block, especially in high-risk areas or patients.
- Epinephrine prolongs the duration of action and reduces systemic absorption of bupivacaine, but it also adds its own cardiovascular effects (tachycardia, hypertension, arrhythmias).
- Contraindicated for use in areas supplied by end-arteries (e.g., fingers, toes, nose, penis, earlobe) due to the risk of vasoconstriction-induced ischemia and necrosis.
- Be prepared to manage systemic toxicity (CNS and cardiovascular) with appropriate resuscitation equipment and medications (e.g., lipid emulsion therapy for bupivacaine toxicity).
- Monitor patients closely for signs of CNS toxicity (e.g., lightheadedness, tinnitus, perioral numbness, seizures) and cardiovascular toxicity (e.g., hypotension, bradycardia, arrhythmias).
Alternative Therapies
- Other local anesthetics without epinephrine (e.g., plain bupivacaine, lidocaine, ropivacaine)
- Regional anesthesia techniques without local anesthetic/epinephrine combination (e.g., nerve blocks with plain local anesthetic)
- General anesthesia
- Systemic analgesics (e.g., opioids, NSAIDs)
- Non-pharmacological pain management techniques